5GURLEY B J, GARDNER S F, HUBBARD M A, et al. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John" swort, garlic oil Panax ginseng and ginkgo biloba [ J ]. Drugs Aging, 2005, 22(6) :525-530. 被引量:1
6GURLEY B J, GARDNERS F, HUBBARD M A, et al. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans [ J ]. Clin Pharm Ther, 2002, 72 (3) :276-280. 被引量:1
7ZHOU J Q, TANG Z Q. Effect of quereetin on CYP1A2, CYP2E1, CYP3A2 activities and its inhibitory mechanism studies in rat liver microsomes [ J ]. J Chin Pharm Sci, 2005, 14(4) :231-236. 被引量:1
5YUAN F,CHEN J,WU W J,et al.Effects of matrine and oxymatrine on catalytic activity of cytochrome P450s in rats[J].Basic Clin Pharmacol Toxicol in press,2010. 被引量:1
6INGELMANSUNDBERG M.Pharmacogenetics of cytochrome P450 and its applications in drug therapy:the past,present and future[J].Trends Pharmacol Sci,2004,25(4):193-200. 被引量:1
7HAO M,ZHAO Y Q,CHEN P Z,et al.Structureactivity relationship and substratedependent phenomena in effects of ginsenosides on activities of drugmetabolizing P450 enzymes[J].Plos One,2008,3(7):2697. 被引量:1
8CERMAK R,WOLFFRAM S.The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms[J].Curr Drug Metab,2006,7(7):729-744. 被引量:1
9WEI W,MA C M,HATTORI M.Metabolism and pharmacokinetics of rhynchophylline in rats[J].Biol Pharm Bull,2010,33(4):669-676. 被引量:1
10FABER M S,JETTER A,FUHR U.Assessment of CYP1A2 activity in clinical practice:why,how,and when?[J].Basic Clin Pharmacol Toxicol,2005,97(3):125-134. 被引量:1